Targeted radiotherapy

RADIATION3 trials

Sponsors

Kanazawa University Hospital, University Hospital Southampton NHS Foundation Trust

Conditions

Acute LeukaemiaChronic LeukaemiaLymphomaMyelomamalignant neuroendocrine tumorsneuroblastoma

Phase 1

Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy

CompletedNCT01521611

University Hospital Southampton NHS Foundation TrustAcute Leukaemia, Chronic Leukaemia, Lymphoma +1

Start: 2002-01-31End: 2018-07-01Updated: 2019-04-08

Unknown Phase

Targeted radiotherapy for chemotherapy resistant neuroblastoma with I-131 metaiodobenzylguanidine (MIBG)

Active, not recruitingJPRN-UMIN000002530

Kanazawa University Hospitalneuroblastoma

Start: 2009-09-11Target: 90Updated: 2026-06-29

Targeted radiotherapy for malignant neuroendocrine tumors with I-131 metaiodobenzylguanidine (MIBG)

Active, not recruitingJPRN-UMIN000002529

Kanazawa University Hospitalmalignant neuroendocrine tumors

Start: 2009-09-11Target: 100Updated: 2026-06-29

Related Papers

Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation.

2024-06-123 citations